PAA
PRTK

Peregrine Asset Advisers’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Peregrine Asset Advisers’s Portfolio PRTK Stock Details PRTK Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,800
Closed -$164K – 119
2016
Q2 		$164K Buy
+11,800
New +$164K 0.11% 102